[3-(Aminomethyl)azetidin-3-yl]methanamine trihydrochloride

Catalog No.: 
ACXADQ893
CAS No.: 
2306262-39-3
Molecular Formula: 
C5H16Cl3N3
Molecular Weight: 
224.56
[3-(Aminomethyl)azetidin-3-yl]methanamine trihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$139.00In stockInquiry
250mg95%$184.00In stockInquiry
500mg95%$307.00In stockInquiry
1g95%$461.00In stockInquiry
5g95%$1379.00In stockInquiry
10g95%$2297.00In stockInquiry
25g95%$4592.00InquiryInquiry
50g95%$7347.00InquiryInquiry
100g95%$11939.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name[3-(Aminomethyl)azetidin-3-yl]methanamine trihydrochloride
IUPAC Nameazetidine-3,3-diyldimethanamine trihydrochloride
MDL No.MFCD31808194
Molecular FormulaC5H16Cl3N3
Molecular Weight224.56
SMILESNCC1(CN)CNC1.[H]Cl.[H]Cl.[H]Cl
InChI KeyKCEFXMXPDPQDPM-UHFFFAOYSA-N
Synonym3-(aminomethyl)azetidin-3-yl]methanamine trihydrochloride;Azetidine-3,3-diyldimethanamine Trihydrochloride;1-[3-(Aminomethyl)azetidin-3-yl]methanamine trihydrochloride;[3-(aminomethyl)azetidin-3-yl]methanamine trihydrochloride - [A85514]
CAS No.2306262-39-3

Synthetic Route by SureRoute

1. ACXADQ893 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXADQ893 route product structure diagram
    ACXADQ8932306262-39-3In Stock
Inquiry

2. ACXADQ893 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXADQ893 route product structure diagram
    ACXADQ8932306262-39-3In Stock
Inquiry

3. ACXADQ893 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXADQ893 route product structure diagram
    ACXADQ8932306262-39-3In Stock
Inquiry

Comments (0)